Literature DB >> 33817152

Long Non-coding RNA DUXAP8 Regulates the Cell Proliferation and Invasion of Non-small-cell Lung Cancer.

Si-Jia Yang1, Jia-Lu Weng2, Bin Wei3, Xue-Kui Du1.   

Abstract

To investigate how long non-coding RNAs DUXAP8 (LncRNA DUXAP8) influence the cell proliferation and invasion of non-small-cell lung cancer (NSCLC), we detected the expression levels of LncRNA DUXAP8 in lung cancer (LC) tissues, 4 LC-related cell lines (A549, SPC-A1, SK-MES-1 and NCI-H1299) and normal lung tissues via quantitative real-time PCR (qRT-PCR). Compared with normal lung tissue, LncRNA DUXAP8 was significantly up-regulated in NSCLC, especially in stage III / IV and diameter ≥ 3cm of lung cancer. Among 4 lung cancer cell lines, LncRNA DUXAP8 in A549 cells was the highest (P<0.001). Construction of LncRNA DUXAP8 overexpression and LncRNA DUXAP8 knockout in A549 cell lines was further performed and subsequently injected into nude mice to build an in vivo tumor xenograft model. The results indicated that LncRNA DUXAP8 overexpression significantly promoted the A549 cells' proliferation, enhanced invasion and induced tumor growth. Conversely, LncRNA DUXAP8 knockout significantly suppressed A549 cells' proliferation, weakened invasion and inhibited tumor growth. Taken together, our results imply that LncRNA DUXAP8 is a potential regulatory molecular marker in non-small-cell lung cancer.
© 2019 Si-Jia Yang et al., published by De Gruyter.

Entities:  

Keywords:  Non-small-cell lung cancer (NSCLC); long non-coding RNA DUXAP8; proliferation and invasion

Year:  2019        PMID: 33817152      PMCID: PMC7874797          DOI: 10.1515/biol-2019-0022

Source DB:  PubMed          Journal:  Open Life Sci        ISSN: 2391-5412            Impact factor:   0.938


  25 in total

Review 1.  Non-small cell lung cancer.

Authors:  David S Ettinger; Wallace Akerley; Gerold Bepler; Matthew G Blum; Andrew Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Apar Kishor P Ganti; Ramaswamy Govindan; Frederic W Grannis; Thierry Jahan; Mohammad Jahanzeb; David H Johnson; Anne Kessinger; Ritsuko Komaki; Feng-Ming Kong; Mark G Kris; Lee M Krug; Quynh-Thu Le; Inga T Lennes; Renato Martins; Janis O'Malley; Raymond U Osarogiagbon; Gregory A Otterson; Jyoti D Patel; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; George R Simon; Scott J Swanson; Douglas E Wood; Stephen C Yang
Journal:  J Natl Compr Canc Netw       Date:  2010-07       Impact factor: 11.908

2.  Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer.

Authors:  L Zhang; S-B Shi; Y Zhu; T-T Qian; H-L Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-01       Impact factor: 3.507

Review 3.  FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer.

Authors:  Dickran Kazandjian; Gideon M Blumenthal; Weishi Yuan; Kun He; Patricia Keegan; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2016-03-15       Impact factor: 12.531

4.  Long non-coding RNA CACNA1G-AS1 promotes cell migration, invasion and epithelial-mesenchymal transition by HNRNPA2B1 in non-small cell lung cancer.

Authors:  P-F Yu; A-R Kang; L-J Jing; Y-M Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-02       Impact factor: 3.507

5.  Mechanism of lncRNA DUXAP8 in promoting proliferation of bladder cancer cells by regulating PTEN.

Authors:  M-G Lin; Y-K Hong; Y Zhang; B-B Lin; X-J He
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-06       Impact factor: 3.507

6.  LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells.

Authors:  Y M Whang; S I Park; I A Trenary; R A Egnatchik; J P Fessel; J M Kaufman; D P Carbone; J D Young
Journal:  Oncogene       Date:  2015-06-29       Impact factor: 9.867

7.  P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression.

Authors:  E-b Zhang; D-d Yin; M Sun; R Kong; X-h Liu; L-h You; L Han; R Xia; K-m Wang; J-s Yang; W De; Y-q Shu; Z-x Wang
Journal:  Cell Death Dis       Date:  2014-05-22       Impact factor: 8.469

8.  The pseudogene derived long noncoding RNA DUXAP8 promotes gastric cancer cell proliferation and migration via epigenetically silencing PLEKHO1 expression.

Authors:  Hong-Wei Ma; Min Xie; Ming Sun; Tian-Yu Chen; Rong-Rong Jin; Tian-Shi Ma; Qin-Nan Chen; Er-Bao Zhang; Xue-Zhi He; Wei De; Zhi-Hong Zhang
Journal:  Oncotarget       Date:  2016-08-05

9.  Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer.

Authors:  Ken Uchibori; Naohiko Inase; Mitsugu Araki; Mayumi Kamada; Shigeo Sato; Yasushi Okuno; Naoya Fujita; Ryohei Katayama
Journal:  Nat Commun       Date:  2017-03-13       Impact factor: 14.919

Review 10.  Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors.

Authors:  Zhonghua Ma; Hesuyuan Huang; Yetao Xu; Xuezhi He; Jirong Wang; Bingqing Hui; Hao Ji; Jing Zhou; Keming Wang
Journal:  Onco Targets Ther       Date:  2017-09-25       Impact factor: 4.147

View more
  2 in total

Review 1.  Functions of lncRNA DUXAP8 in non-small cell lung cancer.

Authors:  Cui Wu; Wu Song; Zhongnan Wang; Bingmei Wang
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.316

2.  LncRNA DUXAP8 as a prognostic biomarker for various cancers: A meta-analysis and bioinformatics analysis.

Authors:  Yongfeng Wang; Xianglai Jiang; Dongzhi Zhang; Yuanbin Zhao; Xiaoyong Han; Lihui Zhu; Jingyao Ren; Yubin Liu; Jiarong You; Haolan Wang; Hui Cai
Journal:  Front Genet       Date:  2022-08-15       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.